Skip to content

FY2027 ICD-10-CM reference

D3A.01: Benign carcinoid tumors of the small intestine

By the HCC Buddy Coding Team

The official ICD-10-CM descriptor is Benign carcinoid tumors of the small intestine. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Nonbillable heading. Verified against the official FY2027 order file.

CMS-HCC V28

Not applicable to this nonbillable heading

CMS-HCC V24

Not applicable to this nonbillable heading

ESRD

Not applicable to this nonbillable heading

PACE

Not applicable to this nonbillable heading

RxHCC

Not applicable to this nonbillable heading

HHS-HCC

Not applicable to this nonbillable heading

More specific FY2027 codes

FY2027 Tabular instructions

Instructions below include applicable chapter, section and parent-code notes. Each note identifies where it appears in the official source.

Instructional note

Functional activity

Source: C00-D49 (chapter, inherited).

Instructional note

All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.

Source: C00-D49 (chapter, inherited).

Instructional note

Morphology [Histology]

Source: C00-D49 (chapter, inherited).

Instructional note

Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.

Source: C00-D49 (chapter, inherited).

Instructional note

Primary malignant neoplasms overlapping site boundaries

Source: C00-D49 (chapter, inherited).

Instructional note

A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.

Source: C00-D49 (chapter, inherited).

Instructional note

Malignant neoplasm of ectopic tissue

Source: C00-D49 (chapter, inherited).

Instructional note

Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

Source: C00-D49 (chapter, inherited).

Code also

any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Source: D3A (category, inherited).

Instructional note

code to identify any associated endocrine syndrome, such as:

Source: D3A (category, inherited).

Instructional note

carcinoid syndrome (E34.00)

Source: D3A (category, inherited).

Excludes2

benign pancreatic islet cell tumors (D13.7)

Source: D3A (category, inherited).

Source: CMS FY2027 Tabular List and Alphabetic Index.

Open Tabular instructions and code details

Compare the FY2027 additions, removals and billable-status changes

What does D3A.01 mean in FY2027?

The official ICD-10-CM descriptor is Benign carcinoid tumors of the small intestine. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Is D3A.01 billable in FY2027?

The FY2027 order file marks D3A.01 as a nonbillable heading. Select a complete billable child code.

Does D3A.01 map to an HCC?

Risk-model mapping is not applicable to this nonbillable heading. Check a complete billable child code.

Source: CMS FY2027 ICD-10-CM order file. Payment model: CMS CY 2027 Rate Announcement. Read the FY2027 Official Guidelines.

Review the FY2026 April edition